Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: Analysis of the on-trial cases for the SCALOP trial.
about
Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer.Challenges for Quality Assurance of Target Volume Delineation in Clinical Trials.Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy.Quantification of MRI visibility and artifacts at 3T of liquid fiducial marker in a pancreas tissue-mimicking phantom.Addition of MRI for CT-based pancreatic tumor delineation: a feasibility study.
P2860
Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: Analysis of the on-trial cases for the SCALOP trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Comparison of investigator-del ...... al cases for the SCALOP trial.
@en
type
label
Comparison of investigator-del ...... al cases for the SCALOP trial.
@en
prefLabel
Comparison of investigator-del ...... al cases for the SCALOP trial.
@en
P2093
P2860
P1476
Comparison of investigator-del ...... al cases for the SCALOP trial.
@en
P2093
Emmanouil Fokas
John Staffurth
Kwun-Ye Chu
Lisette Nixon
Neel Patel
Ross Abrams
Somnath Mukherjee
P2860
P304
P356
10.1016/J.RADONC.2016.07.002
P577
2016-08-03T00:00:00Z